These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8951284)

  • 1. Prevention of hepatitis A infections: guidelines for use of hepatitis A vaccine and immune globulin. American Academy of Pediatrics Committee on Infectious Diseases.
    Pediatrics; 1996 Dec; 98(6 Pt 1):1207-15. PubMed ID: 8951284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testing for antibody to hepatitis A to decrease the cost of hepatitis A prophylaxis with immune globulin or hepatitis A vaccines.
    Bryan JP; Nelson M
    Arch Intern Med; 1994 Mar; 154(6):663-8. PubMed ID: 8129500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and effectiveness of the new inactivated hepatitis A virus vaccine.
    Furesz J; Scheifele DW; Palkonyay L
    CMAJ; 1995 Feb; 152(3):343-8. PubMed ID: 7828098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis A vaccine versus immune globulin for postexposure prophylaxis.
    Victor JC; Monto AS; Surdina TY; Suleimenova SZ; Vaughan G; Nainan OV; Favorov MO; Margolis HS; Bell BP
    N Engl J Med; 2007 Oct; 357(17):1685-94. PubMed ID: 17947390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of hepatitis A virus infection.
    Moyer L; Warwick M; Mahoney FJ
    Am Fam Physician; 1996 Jul; 54(1):107-14. PubMed ID: 8677827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis A vaccine recommendations.
    American Academy of Pediatrics Committee on Infectious Diseases
    Pediatrics; 2007 Jul; 120(1):189-99. PubMed ID: 17606579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The underestimated risk of hepatitis A and hepatitis B: benefits of an accelerated vaccination schedule.
    Keystone JS; Hershey JH
    Int J Infect Dis; 2008 Jan; 12(1):3-11. PubMed ID: 17643334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity and safety of a new inactivated hepatitis A vaccine in Thai young adults.
    Vimolket T; Theamboonlers A; Dumas R; Milcamps B; Forrat R; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 1998 Dec; 29(4):779-85. PubMed ID: 10772564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supplementary statement on hepatitis A prevention.
    Can Commun Dis Rep; 1996 Jan; 22(1):1-3. PubMed ID: 8825660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A two-dose schedule for combined hepatitis A and B vaccination in children aged 6-15 years.
    Kurugöl Z; Mutlubaş F; Ozacar T
    Vaccine; 2005 Apr; 23(22):2876-80. PubMed ID: 15780736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and safety of an inactivated hepatitis A vaccine in Taiwanese adults and children.
    Lee CY; Huang LM; Lee PI; Chiu HH; Dumas R; Milcamps B; Lin W
    Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):29-36. PubMed ID: 11023061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivated hepatitis A vaccine: immunogenicity, efficacy, safety and review of official recommendations for use.
    André F; Van Damme P; Safary A; Banatvala J
    Expert Rev Vaccines; 2002 Jun; 1(1):9-23. PubMed ID: 12908508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
    Kallinowski B; Jilg W; Buchholz L; Stremmel W; Engler S
    Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity, safety, and interchangeability of two inactivated hepatitis A vaccines in Chilean children.
    Abarca K; Ibánez I; Perret C; Vial P; Zinsou JA
    Int J Infect Dis; 2008 May; 12(3):270-7. PubMed ID: 17988917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recommendations for protection against viral hepatitis. Recommendation of the Immunization Practices Advisory Committee. Centers for Disease Control, Department of Health and Human Services.
    Ann Intern Med; 1985 Sep; 103(3):391-402. PubMed ID: 3161440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vaccination against hepatitis A].
    Balli F; Di Biase AR; Viola L
    Pediatr Med Chir; 1996; 18(3):259-62. PubMed ID: 8966125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update: Recommendations of the Advisory Committee on Immunization Practices for Use of Hepatitis A Vaccine for Postexposure Prophylaxis and for Preexposure Prophylaxis for International Travel.
    Nelson NP; Link-Gelles R; Hofmeister MG; Romero JR; Moore KL; Ward JW; Schillie SF
    MMWR Morb Mortal Wkly Rep; 2018 Nov; 67(43):1216-1220. PubMed ID: 30383742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Committee on Native American Child Health and Committee on Infectious Diseases. Immunizations for Native American children. American Academy of Pediatrics.
    Pediatrics; 1999 Sep; 104(3 Pt 1):564-7. PubMed ID: 10469787
    [No Abstract]   [Full Text] [Related]  

  • 19. Hepatitis A vaccine in the last-minute traveler.
    Connor BA
    Am J Med; 2005 Oct; 118 Suppl 10A():58S-62S. PubMed ID: 16271543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis A vaccination programs in communities with high rates of hepatitis A.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Jul; 46(26):600-3. PubMed ID: 9221328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.